Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024491490> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2024491490 endingPage "295" @default.
- W2024491490 startingPage "291" @default.
- W2024491490 abstract "Leflunomide is a disease-modifying antirheumatic drug (DMARD) with comparable efficacy to methotrexate in the treatment of rheumatoid arthritis. We compared the pharmacokinetic characteristics of two leflunomide formulations in healthy subjects and assessed whether these formulations were bioequivalent.A randomized, two-way, crossover study was conducted in 24 healthy male volunteers to compare the pharmacokinetics of two leflunomide formulations after administration of a single 20 mg dose of each drug with a 7 week washout period. Blood samples for the analysis of A77 1726, the main active metabolite of leflunomide, were obtained 624 h after drug administration.After administering a single dose of 20 mg of each leflunomide formulation, the mean AUC(0-t) and Cmax values of A771726 were 487.3 +/- 167.6 microg*h/ml and 2.24 +/- 0.85 microg/ml for the reference formulation and 468.5 +/- 148.6 microg*h/ml and 1.98 +/- 0.45 microg/ml for the test formulation, respectively. The 90% confidence intervals of the test/reference mean ratios for AUC(0-t), AUC(0-inf), and Cmax fell within the predetermined equivalence range of 0.8 - 1.25. No serious adverse events occurred during the study period.The two leflunomide formulations showed similar pharmacokinetic profiles in terms of A77 1726, and the test formulation was found to be bioequivalent to the reference formulation with respect to the rate and extent of leflunomide absorption." @default.
- W2024491490 created "2016-06-24" @default.
- W2024491490 creator A5015481616 @default.
- W2024491490 creator A5017133442 @default.
- W2024491490 creator A5018998884 @default.
- W2024491490 creator A5019257755 @default.
- W2024491490 creator A5031779311 @default.
- W2024491490 creator A5043248382 @default.
- W2024491490 date "2010-04-01" @default.
- W2024491490 modified "2023-09-27" @default.
- W2024491490 title "Pharmacokinetic comparison and bioequivalence of two leflunomide formulations in humans: a single dose, randomized, open-label, two-way crossover study" @default.
- W2024491490 doi "https://doi.org/10.5414/cpp48291" @default.
- W2024491490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20353751" @default.
- W2024491490 hasPublicationYear "2010" @default.
- W2024491490 type Work @default.
- W2024491490 sameAs 2024491490 @default.
- W2024491490 citedByCount "4" @default.
- W2024491490 countsByYear W20244914902013 @default.
- W2024491490 countsByYear W20244914902021 @default.
- W2024491490 crossrefType "journal-article" @default.
- W2024491490 hasAuthorship W2024491490A5015481616 @default.
- W2024491490 hasAuthorship W2024491490A5017133442 @default.
- W2024491490 hasAuthorship W2024491490A5018998884 @default.
- W2024491490 hasAuthorship W2024491490A5019257755 @default.
- W2024491490 hasAuthorship W2024491490A5031779311 @default.
- W2024491490 hasAuthorship W2024491490A5043248382 @default.
- W2024491490 hasConcept C112705442 @default.
- W2024491490 hasConcept C126322002 @default.
- W2024491490 hasConcept C142724271 @default.
- W2024491490 hasConcept C204787440 @default.
- W2024491490 hasConcept C22979827 @default.
- W2024491490 hasConcept C27081682 @default.
- W2024491490 hasConcept C2775905006 @default.
- W2024491490 hasConcept C2777575956 @default.
- W2024491490 hasConcept C42404028 @default.
- W2024491490 hasConcept C71924100 @default.
- W2024491490 hasConcept C87813604 @default.
- W2024491490 hasConcept C98274493 @default.
- W2024491490 hasConceptScore W2024491490C112705442 @default.
- W2024491490 hasConceptScore W2024491490C126322002 @default.
- W2024491490 hasConceptScore W2024491490C142724271 @default.
- W2024491490 hasConceptScore W2024491490C204787440 @default.
- W2024491490 hasConceptScore W2024491490C22979827 @default.
- W2024491490 hasConceptScore W2024491490C27081682 @default.
- W2024491490 hasConceptScore W2024491490C2775905006 @default.
- W2024491490 hasConceptScore W2024491490C2777575956 @default.
- W2024491490 hasConceptScore W2024491490C42404028 @default.
- W2024491490 hasConceptScore W2024491490C71924100 @default.
- W2024491490 hasConceptScore W2024491490C87813604 @default.
- W2024491490 hasConceptScore W2024491490C98274493 @default.
- W2024491490 hasIssue "04" @default.
- W2024491490 hasLocation W20244914901 @default.
- W2024491490 hasLocation W20244914902 @default.
- W2024491490 hasOpenAccess W2024491490 @default.
- W2024491490 hasPrimaryLocation W20244914901 @default.
- W2024491490 hasRelatedWork W2003186780 @default.
- W2024491490 hasRelatedWork W2033685750 @default.
- W2024491490 hasRelatedWork W2053536280 @default.
- W2024491490 hasRelatedWork W2055974197 @default.
- W2024491490 hasRelatedWork W2087796686 @default.
- W2024491490 hasRelatedWork W2374069256 @default.
- W2024491490 hasRelatedWork W2381431760 @default.
- W2024491490 hasRelatedWork W2604757141 @default.
- W2024491490 hasRelatedWork W2915308879 @default.
- W2024491490 hasRelatedWork W4366603634 @default.
- W2024491490 hasVolume "48" @default.
- W2024491490 isParatext "false" @default.
- W2024491490 isRetracted "false" @default.
- W2024491490 magId "2024491490" @default.
- W2024491490 workType "article" @default.